» Articles » PMID: 37100944

Are Repeat COVID Infections Dangerous? What the Science Says

Overview
Journal Nature
Specialty Science
Date 2023 Apr 26
PMID 37100944
Authors
Affiliations
Soon will be listed here.
Citing Articles

Unlike common pneumonia, COVID-19 is a risk factor for multiple cardiovascular diseases: A two-sample Mendelian randomization study.

Li C, Chen H Medicine (Baltimore). 2025; 103(52):e41015.

PMID: 39969327 PMC: 11688020. DOI: 10.1097/MD.0000000000041015.


Mixed lipopeptide-based mucosal vaccine candidate induces cross-variant immunity and protects against SARS-CoV-2 infection in hamsters.

Patel R, Duque D, Bavananthasivam J, Hewitt M, Sandhu J, Kumar R Immunohorizons. 2025; 9(2).

PMID: 39849995 PMC: 11841972. DOI: 10.1093/immhor/vlae011.


Spontaneous retroperitoneal hematoma after COVID-19 infection: A case report.

Chen X, Li Z, Zou L, Lan Y, Wu X, Wang H Medicine (Baltimore). 2025; 104(2):e41077.

PMID: 39792712 PMC: 11729266. DOI: 10.1097/MD.0000000000041077.


COVID-19 Vaccination and Transient Increase in CD4/CD8 Cell Counts in People with HIV: Evidence from China.

Li Y, Lin Y, Yi Y, Zhu N, Cui X, Li X Vaccines (Basel). 2025; 12(12.

PMID: 39772028 PMC: 11680300. DOI: 10.3390/vaccines12121365.


Short-chain fatty acids play a key role in antibody response to SARS-CoV-2 infection in people living with HIV.

Pan J, Zhang X, Shi D, Tian X, Xu L, Lu X Sci Rep. 2024; 14(1):31211.

PMID: 39732792 PMC: 11682251. DOI: 10.1038/s41598-024-82596-0.


References
1.
Guedes A, Oliveira M, Tavares B, Luna-Muschi A, Dos Santos Lazari C, Montal A . Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic. Sci Rep. 2023; 13(1):712. PMC: 9837751. DOI: 10.1038/s41598-022-25908-6. View

2.
Eythorsson E, Runolfsdottir H, Ingvarsson R, Sigurdsson M, Palsson R . Rate of SARS-CoV-2 Reinfection During an Omicron Wave in Iceland. JAMA Netw Open. 2022; 5(8):e2225320. PMC: 9350711. DOI: 10.1001/jamanetworkopen.2022.25320. View

3.
Abu-Raddad L, Chemaitelly H, Bertollini R . Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections. N Engl J Med. 2021; 385(26):2487-2489. PMC: 8631440. DOI: 10.1056/NEJMc2108120. View

4.
Mensah A, Lacy J, Stowe J, Seghezzo G, Sachdeva R, Simmons R . Disease severity during SARS-COV-2 reinfection: a nationwide study. J Infect. 2022; 84(4):542-550. PMC: 8786677. DOI: 10.1016/j.jinf.2022.01.012. View

5.
Bowe B, Xie Y, Al-Aly Z . Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med. 2022; 28(11):2398-2405. PMC: 9671810. DOI: 10.1038/s41591-022-02051-3. View